Provided by Tiger Trade Technology Pte. Ltd.

Editas Medicine

2.90
+0.06002.11%
Post-market: 2.910.0100+0.34%19:54 EDT
Volume:3.09M
Turnover:8.93M
Market Cap:443.70M
PE:-3.97
High:2.97
Open:2.85
Low:2.71
Close:2.84
52wk High:4.33
52wk Low:1.66
Shares:153.00M
Float Shares:115.00M
Volume Ratio:0.94
T/O Rate:2.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7307
EPS(LYR):-1.8036
ROE:-118.82%
ROA:-23.29%
PB:4.21
PE(LYR):-1.61

Loading ...

Editas wins approval to launch EDIT-401 Strive trial

TIPRANKS
·
Oct 08

Editas Medicine Receives Approval in Australia for Phase 3 Trial of EDIT-401 to Treat Hyperlipidemia

MT Newswires Live
·
Oct 08

Editas Medicine receives approval to initiate clinical trial of EDIT-401

TIPRANKS
·
Oct 08

Editas Wins Australian Clearance to Start Phase 1/2 EDIT-401 Trial in HeFH Patients

Reuters
·
Oct 08

Editas Medicine - Expects Topline Safety and Efficacy Data for Edit-401 Later in 2027

THOMSON REUTERS
·
Oct 08

Editas Medicine - to Begin Patient Dosing in 2026, Report Initial Data in Q1 2027

THOMSON REUTERS
·
Oct 08

Editas Medicine Receives Approval to Initiate First-in-Human Clinical Trial of Edit-401 in Patients with Hyperlipidemia

THOMSON REUTERS
·
Oct 08

Editas slips amid pressure on gene-editing sector after Anthropic update

TIPRANKS
·
Sep 24

Editas Medicine Raised to Buy from Neutral by Guggenheim

Dow Jones
·
Sep 23

Guggenheim Upgrades Editas Medicine to Buy From Neutral, Price Target is $5

MT Newswires Live
·
Sep 23

Top Premarket Gainers

MT Newswires Live
·
Sep 15

Editas Medicine EVP, Chief Medical Officer Daniel Ory Files Initial Beneficial Ownership Statement

Reuters
·
Sep 10

Editas Grants New CMO Daniel Ory Stock Options for 950,000 Shares at USD 3.03 Each

Reuters
·
Sep 09

Press Release: Editas Medicine Reports Inducement Grants to New Chief Medical Officer

Dow Jones
·
Sep 09

Press Release: Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer

Dow Jones
·
Sep 08

Editas Medicine Appoints Dan Ory, M.d., as Chief Medical Officer

THOMSON REUTERS
·
Sep 08

Editas Medicine to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Sep 01

Editas Medicine Files $400 Million Mixed Shelf

MT Newswires Live
·
Sep 01

Editas Medicine files $400M mixed securities shelf

TIPRANKS
·
Sep 01

Editas Medicine - May Offer up to $400 Mln of Securities - SEC Filing

THOMSON REUTERS
·
Sep 01